呼气压力缓解算法对OSA患者上气道通畅性及CPAP疗效的影响:一项随机研究
结果显示EPA激活后吸气峰流量降低、手动滴定所需CPAP压力升高、残余AHI在固定与自动CPAP下均升高,但CPAP依从性无显著变化。提示EPA可能损害上气道通畅性并影响OSA控制。
要点
- EPA激活后吸气峰流量较无EPA时降低,提示上气道通畅性受损。
- EPA激活时手动滴定CPAP水平高于无EPA时,需更高治疗压力。
- EPA激活后固定与自动CPAP下残余AHI均升高,但依从性无显著变化。
核心结论
- EPA应用损害上气道通畅性,需要比无EPA时更高的治疗性CPAP压力。
- EPA损害OSA控制,但不影响CPAP依从性。
研究设计与样本
- 步骤1和2在单夜多导睡眠监测中完成:步骤1测量有无EPA时吸气流量受限期间的吸气峰流量;步骤2按随机顺序进行有无EPA的CPAP滴定。
- 步骤3和4在家中进行:比较固定CPAP(步骤3)和自动CPAP(步骤4)下有无EPA激活时的残余AHI和依从性。
- 患者特征:55%女性;平均年龄±SD 63±12岁;平均BMI±SD 37±7 kg/m2;AHI 58 events/h(39-83)。
主要发现
- EPA激活降低吸气峰流量:0.38(0.34-0.42)vs 无EPA 0.19(0.15-0.23)L/s,P < .001。
- 手动滴定CPAP水平EPA高于无EPA:11.40±1.95 vs 9.17±1.78 cm H2O,P < .001。
- 固定CPAP下残余AHI EPA高于无EPA:3.7±2.2 vs 1.3±0.6 events/h,P < .05。
- 自动CPAP下残余AHI EPA高于无EPA:1.4(0.6-2.1)vs 0.8(0.5-1.8)events/h,P < .05。
- CPAP依从性无显著变化:固定CPAP 7.0±0.8 vs 7.2±1.0小时(P = .497);自动CPAP 7.0±1.3 vs 6.9±1.3小时(P = .506)。
关键数值与推荐
- EPA激活时吸气峰流量为0.38(0.34-0.42)L/s,无EPA时为0.19(0.15-0.23)L/s,P < .001。
- 手动滴定CPAP水平EPA为11.40±1.95 cm H2O,无EPA为9.17±1.78 cm H2O,P < .001。
- 固定CPAP残余AHI EPA为3.7±2.2 events/h,无EPA为1.3±0.6 events/h,P < .05。
- 自动CPAP残余AHI EPA为1.4(0.6-2.1)events/h,无EPA为0.8(0.5-1.8)events/h,P < .05。
- CPAP依从性固定CPAP P = .497,自动CPAP P = .506。
临床怎么用
- 对重度OSA患者使用含EPA算法的CPAP时,需注意其可能降低上气道通畅性并需更高治疗压力。
- EPA激活可能升高残余AHI,临床应监测OSA控制情况。
- EPA对CPAP依从性无显著影响,但需结合个体化评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Expiratory pressure alleviation (EPA) algorithms have been incorporated into CPAP devices to reduce expiratory discomfort during treatment of OSA. Because pharyngeal narrowing or collapse can occur during expiration, EPA may impair upper airway patency. RESEARCH QUESTION: Does EPA compromise upper airway patency and CPAP efficacy in patients with severe OSA? STUDY DESIGN AND METHODS: Adults with severe OSA using nasal CPAP were considered to participate. The study was conducted in 4 steps. Steps 1 and 2 were performed during a single overnight polysomnography study. In step 1, peak inspiratory flow (PIF) was measured during inspiratory flow limitation with and without EPA. In step 2, CPAP titration was performed in randomized order with and without EPA. Steps 3 and 4 were conducted at home. Residual apnea-hypopnea index (AHI) and adherence were compared with and without EPA activation during fixed (step 3) and auto-CPAP (step 4). RESULTS: Twenty-nine patients were studied (55% female; mean age ± SD, 63 ± 12 years; mean BMI ± SD, 37 ± 7 kg/m2; AHI, 58 events/h; 39-83). EPA activation reduced PIF compared with no EPA (0.38; 0.34-0.42 vs 0.19; 0.15-0.23 L/s, respectively; P < .001). The manually titrated CPAP level was higher with EPA than without EPA (11.40 ± 1.95 vs 9.17 ± 1.78 cm H2O, respectively; P < .001). The residual AHI was higher with EPA than without EPA during fixed (3.7 ± 2.2 vs 1.3 ± 0.6 events/h) and automatic CPAP (1.4; 0.6-2.1 vs 0.8; 0.5-1.8 events/h, respectively; P < .05). No significant change in CPAP adherence was observed during fixed (7.0 ± 0.8 vs 7.2 ± 1.0 hours) and automatic CPAP (7.0 ± 1.3 vs 6.9 ± 1.3 hours), with (P = .497) and without (P = .506) EPA, respectively. INTERPRETATION: Our results show that EPA application compromised upper airway patency and required higher therapeutic CPAP than without EPA. EPA also impaired OSA control but did not impact CPAP adherence. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov; No.: NCT05219591; URL: www. CLINICALTRIALS: gov.
引用
- Grad GF, Rosanelli I, Fernandes MD, et al. Impairment of Upper Airway Patency and CPAP Effectiveness During OSA Treatment With Expiratory Pressure Alleviation: A Randomized Study. Chest. 2026. PMID: 42692288. doi:10.1016/j.chest.2026.08.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。